ET Healthcare
Shanghai
About ET Healthcare
ET Healthcare develops an automated immunodiagnostics solution designed to address comprehensive needs, including inflammation, cardiac function, fertility, infectious diseases, and tumors. Pylon, a product from ET Healthcare, is intended to bring immunoassay performance typically associated with central lab analyzers to the near-patient setting. This entails addressing specific near-patient testing requirements such as reduced facility requirements for space, plumbing, and electricity, as well as lower demand for human resources such as trained operators or staff numbers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $129.5M
- Funding stage: Late Stage Venture
- Last round: Series G (Apr 2021)
- Website: ethealthcare.com.cn
Industries & Categories
Biotechnology, Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/et-healthcare-125204 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.